Thank you for your interest in clinical trials for Renick and the surrounding suburbs. Please view all available clinical trials in Renick below. If you receive too many clinical trial listings you may enter keywords and/or reduce search distance.
Your search returned no results. Get alerts when studies become available.
Your search returned 11 studies. (Get alerts for new studies):Connect™ CLL: The Chronic Lymphocytic Leukemia Disease RegistryConditions: Chronic Lymphocytic LeukemiaLocation: Low Moor, Virginia Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus PlacConditions: Metastatic Breast CancerLocation: Low Moor, Virginia Noninvasive Biomarkers for Monitoring Cardiometabolic Risk in ChildrenConditions: Obesity - Metabolic SyndromeLocation: Lewisburg, West Virginia Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone CancerConditions: Breast CancerLocation: Lewisburg, West Virginia A Study of the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic ControlConditions: Type 2 Diabetes MellitusLocation: Lewisburg, West Virginia Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or NaproxenConditions: Arthritis, Rheumatoid - OsteoarthritisLocation: Beckley, West Virginia Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or NaproxenConditions: Arthritis, Rheumatoid - OsteoarthritisLocation: Lewisburg, West Virginia A Study of RoActemra/Actemra (Tocilizumab) in Comparison to Etanercept in Patients With Rheumatoid Arthritis and Cardiovascular Disease Risk FactorsConditions: Cardiovascular Disease, Rheumatoid ArthritisLocation: Beckley, West Virginia A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate CancerConditions: Advanced Prostate Cancer - Prostatic NeoplasmsLocation: Beckley, West Virginia A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa BiologicsConditions: Inflammation - Rheumatoid ArthritisLocation: Beckley, West Virginia A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to MethotrexateConditions: Inflammation - Rheumatoid ArthritisLocation: Beckley, West Virginia
Didn't find what you were looking for? Try these alternatives: